Biogen | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.8M 35K 2025-03
Amgen USD 33.58B 45M 2025-03
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 0 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
United Therapeutics USD 800K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Biogen Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.